Harmony Biosciences Holdings logo
Harmony Biosciences Holdings HRMY
$ 33.85 -0.12%

Quarterly report 2024-Q3
added 10-29-2024

report update icon

Harmony Biosciences Holdings Income Statement 2011-2024 | HRMY

Annual Income Statement Harmony Biosciences Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.85 B 2.65 B 2.06 B 924 M - - - - - - - - -

Shares

59.5 M 59.2 M 57.5 M 25.8 M - - - - - - - - -

Historical Prices

31.1 44.8 35.9 35.9 - - - - - - - - -

Net Income

129 M 181 M 34.6 M -36.9 M -152 M -39.9 M - - - - - - -

Revenue

582 M 438 M 305 M 160 M 6 M - - - - - - - -

Cost of Revenue

121 M 83.5 M 55.5 M 27.7 M 1.58 M - - - - - - - -

Gross Profit

461 M 354 M 250 M 132 M 4.42 M - - - - - - - -

Operating Income

192 M 120 M 87.5 M 17 M -146 M - - - - - - - -

Interest Expense

23.8 M 18.8 M 24.2 M -3.07 M - - - - - - - - -

EBITDA

193 M 121 M 87.9 M 17.4 M -143 M -41.3 M - - - - - - -

Operating Expenses

269 M 234 M 162 M 115 M 150 M - - - - - - - -

General and Administrative Expenses

95.3 M 84 M 63.9 M 39.7 M 36.4 M 12.2 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Harmony Biosciences Holdings

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

56.9 M 56.8 M 56.8 M 56.8 M 59.9 M 60 M 59.7 M 59.6 M 59.2 M 59.1 M 58.9 M 58.8 M 57.7 M 56.9 M 56.9 M 56.9 M 30.2 M 7.81 M 7.79 M 7.79 M 7.78 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

46.1 M 11.6 M 38.3 M - 38.5 M 34.3 M 29.5 M - 87.9 M 23.5 M 21.5 M - -9.62 M 14.1 M 7.39 M - 1.91 M -27 K -38.6 M - -31.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

186 M 173 M 155 M - 160 M 134 M 119 M - 117 M 107 M 85.3 M - 80.7 M 73.8 M 59.7 M - 45.6 M 38 M 19.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

42.8 M 32.1 M 27.5 M - 32.3 M 25 M 20.8 M - 23 M 18.9 M 14.7 M - 14.6 M 12.7 M 10.4 M - 7.89 M 6.46 M 3.47 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

143 M 141 M 127 M - 128 M 109 M 98.3 M - 94.2 M 88.1 M 70.6 M - 66.1 M 61.1 M 49.3 M - 37.7 M 31.5 M 16.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

61.7 M 21.4 M 52 M - 64.5 M 46.9 M 40.4 M - 11.9 M 33.1 M 27.6 M - 21.1 M 23.3 M 14.5 M - 10.4 M 7.31 M -9.61 M - -29.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

-124 K 37 K 4.54 M - -5 K -31 K 5.73 M - 56 K 42 K -2 K - -15 K 4 K -20 K - -1.52 M -400 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

67.7 M 27.3 M 52.2 M - 70.5 M 52.9 M 40.5 M - 17.9 M 39.1 M 27.7 M - 21.4 M 27.9 M 14.6 M - 10.7 M 7.5 M -9.51 M - -29.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

81.6 M 119 M 75.1 M - 63.5 M 62.3 M 57.9 M - 82.3 M 55 M 43 M - 45.1 M 37.8 M 34.7 M - 27.3 M 24.2 M 26 M - 29.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

28.6 M 27.2 M 25.7 M - 22.5 M 22.8 M 22.1 M - 21.3 M 22.2 M 17.9 M - 16.9 M 14.3 M 14.5 M - 10.5 M 7.63 M 9.29 M - 12.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency